KI-Beratung Beta

Gutscheinbedingungen

**Gültig bis 18.11.2026 auf englischsprachige Klassiker (klassiker-32728) online auf thalia.at und in der Thalia App. Einzelne Artikel können ausgeschlossen sein. Ausgenommen sind preisgebundene Artikel & eBooks. Pro Einkauf einmal einlösbar. Click & Collect nur bei Onlinevorabzahlung möglich. Keine Barauszahlung. Nicht kombinierbar mit anderen Aktionen und Gutscheinen. Gutschein wird auf max. 500€ Bestellwert angerechnet. Nicht gültig für Geschenkkarten, Versandkosten und Services.

Produktbild: Cardiovascular Complications in Cancer Therapy
- 11%

Cardiovascular Complications in Cancer Therapy

11% sparen

116,99 € UVP 131,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

This proposed text is designed to provide a useful and comprehensive resource and state-of-the-art overview to readers about vascular damage  potentially induced by antineoplastic drugs.  Thanks to more and more effective antineoplastic treatments the survival of cancer patients is enormously increasing,...

Beschreibung

This proposed text is designed to provide a useful and comprehensive resource and state-of-the-art overview to readers about vascular damage  potentially induced by antineoplastic drugs. 
Thanks to more and more effective antineoplastic treatments the survival of cancer patients is enormously increasing, but at the same time it is increasing the burden of related cardiovascular complications that affect morbidity and mortality. On this basis a new branch of cardiology has been developed, that is Cardio-Oncology. The aim is to prevent cardiovascular complications related to cancer therapy and to facilitate and avoid interruption of antineoplastic drugs due to the occurrence of cardiovascular damage. An increasing attention has been given to cardiac damage, while, until today, vascular complications have been poorly evaluated. 
The aim of this book is to focus on vascular complications related to cancer treatment, to guide the clinician at facing,during his every day practice, cardiovascular toxicity in cancer and hematologic patients. 
The proposed sections of the book have been structured to review the molecular mechanisms underlying vascular damage induced by new and old treatments, to describe the various manifestations of vascular disease that may range from artery to venous disease (including coronary artery disease, peripheral arterial disease, venous thromboembolism and pulmonary hypertension), and to provide advice to monitor patients undergoing onco-hematologic treatments in order to prevent and eventually manage vascular damage.
This book will address resident and fellow physicians, medical oncologists, cardiologists, general practitioners and all those who take care of these patients.
All invited authors will be recognized experts in their field, and leading international researchers on these topics. The editor has worked with these expert colleagues on a variety of other projects.The authors will provide their manuscript according to current literature and clinical research studies. 
The book does not seek to duplicate or replace other current resources. Rather, it will create a comprehensive yet concise resource on this emerging topic that is not adequately covered by any current literature.

Portrait

Antonio Russo, MD, PhDFull Professor of Medical OncologyDepartment of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.)University of Palermo, ItalyDirector of Medical Oncology Section, University Hospital P. GiacconePalermo, Italy Giuseppina Novo, MD, PhDAssociate Professor of CardiologyBiomedic Department of Internal Medicine and Specialities (DIBIMIS) University of Palermo, ItalyDivision of Cardiology, University Hospital P. GiacconePalermo, ItalyPatrizio Lancellotti, MD, PhDUniversity of Liège Hospital, GIGA Cardiovascular SciencesDepartment of CardiologyCHU Sart Tilman, Liège, BelgiumGruppo Villa Maria Care and Research, Anthea HospitalBari, ItalyAntonio Giordano, MD PhD  Director, Sbarro Institute for Cancer Research and Molecular Medicine and Center of BiotechnologyCollege of Science and TechnologyTemple UniversityPA 19122USAFausto J.Professor, University Hospital Santa Maria, CHLNUniversity of Lisbon, PortugalDept. of CardiologyAv Prof Egas MonizLisboa 1649-028 Portugal

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.02.2019

Abbildungen

XIII, 224 p. 41 illus., 38 illus. in color.

Herausgeber Antonio Russo + weitere

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.02.2019

Abbildungen

XIII, 224 p. 41 illus., 38 illus. in color.

Herausgeber
Verlag Springer
Seitenzahl

224

Maße (L/B/H)

25,4/17,8/1,3 cm

Gewicht

521 g

Sprache

Englisch

ISBN

978-3-030-06653-6

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Cardiovascular Complications in Cancer Therapy
  • Introduction.- Mechanisms of Cardiovascular Damage Induced by Traditional Chemotherapy.- Molecular Mechanisms of Cardiovascular Damage Induced by Anti HER2 Therapies.- Cardiovascular Damage Induced by Radiotherapy.- Cardiovascular Damage Induced by Anti-VEGF Therapy.- Cardiovascular Damage Induced by Anti-BCR-ABL TKIs.- Heart Failure and Left Ventricular Dysfunction.- Coronary Artery Disease.- Peripheral Artery Disease and Stroke.- Valvular Heart Disease.- Arterial Hypertension.- Atrial Fibrillation in Cancer.- Management of QT Prolongation Induced by Anti-cancer Drugs.- Pulmonary Hypertension Induced by Anti-cancer Drugs.- Venous Thromboembolism.- Early Detection of Cardiac Damage.- Diagnosis of Cardiac Damage: Role of Stress Echo.- Early Detection and Monitoring of Vascular Damage.- Prevention and Clinical Management of Cardiovascular Damage Induced by Anticancer Drugs: Need for Early Biomarkers and Cardio- and Vasculo-Protection in Personalized Therapy.- Cardiovascular Damage in Clinical Trials.